Purpose Genetic testing has advanced significantly since the publication of the 2011 HRS/EHRA
Expert Consensus Statement on the State of Genetic Testing for the Channelopathies …

Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …

The Trans-Omics for Precision Medicine (TOPMed) programme seeks to elucidate the genetic
architecture and biology of heart, lung, blood and sleep disorders, with the ultimate goal of …

… (n = 2) cell lines; and primary hematopoietic cells (n = 4) as well as purified differentiated
hematopoietic cells (n = 11), and a variety of multipotent progenitor and pluripotent cells (n = 19)…

Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …

The reduction of mortality from sudden cardiac arrest (SCA) in the setting of coronary heart
disease (CHD) remains a major challenge, especially among patients with type 2 diabetes. …

Background— DNA methylation leaves a long-term signature of smoking exposure and is one
potential mechanism by which tobacco exposure predisposes to adverse health outcomes…

… 2 In North America and Europe the annual incidence of SCD ranges between 50 to 100 per
… arrest, the overall survival rate in a recent North American analysis was 4.6%. 8 SCD can …

Atrial fibrillation is a highly prevalent arrhythmia and a major risk factor for stroke, heart failure
and death 1 . We conducted a genome-wide association study (GWAS) in individuals of …

… The 1989–1990 examination was considered baseline for 3768 (≈65%) of the eligible CHS
participants in this analysis, while 1992–1993 was the baseline examination for the rest (n=…